GLOSSARY

Microbiota Transfer is a broad community-transfer term, with origin, preparation and delivery defining benefit and risk.

Microbiota transfer or microbiome-based therapeutics are clinical interventions with defined indications and assessment, not general athlete-performance upgrades. Donor screening, preparation and oversight reduce but do not eliminate pathogen-transfer risk. A healthy or elite-athlete donor does not guarantee safety or benefit. This differs from eating fermented food and should not become a home procedure. Treatment evidence belongs to the actual indication rather than being generalized to every digestive complaint.

Antibiotics can alter community composition and function, with recovery varying between people. Post-antibiotic diarrhea has different causes, sometimes requiring infection assessment rather than a dysbiosis label alone. Do not discontinue necessary treatment solely from microbiome concerns. Tolerable dietary variety and symptom follow-up matter. Neither every probiotic nor one universal restoration program is an established solution for everyone; product-specific evidence and the actual clinical situation remain necessary.

An association between microbes and health or performance does not alone establish microbial causation. Diet and training can influence both, and culture or animal findings are not direct human prescriptions. Sports-benefit claims need relevant human outcomes for the actual intervention. An axis name or biological pathway cannot replace evidence of a practical effect, especially when a product is marketed using results from a different population or formulation.